SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-081616
Filing Date
2022-03-22
Accepted
2022-03-22 16:11:39
Documents
5
Effectiveness Date
2022-03-22

Document Format Files

Seq Description Document Type Size
1 S-8 d336037ds8.htm S-8 59565
2 EX-5.1 d336037dex51.htm EX-5.1 6898
3 EX-23.1 d336037dex231.htm EX-23.1 1173
4 EX-FILING FEES d336037dexfilingfees.htm EX-FILING FEES 25412
5 GRAPHIC g336037g0319044505213.jpg GRAPHIC 3252
  Complete submission text file 0001193125-22-081616.txt   98724
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263763 | Film No.: 22759629
SIC: 2834 Pharmaceutical Preparations